Where Now for Third-party Devices Assessment?

Part of the implementation of ANZTPA promised some much needed regulatory reforms, not least third-party assessment of medical devices. Rapid and cost effective regulatory oversight through third-party assessment is available in North America, Europe and Japan for the overwhelming majority of devices. With indefinite postponement of ANZTPA, AusBiotech continues to work with government to bring in this much needed medical devices regulatory reform.